Free tool
Rare disease stocks
We cover 8 companies grouped under the Rare disease theme. The median market value in the group is $5.25B. Across the group, the median move over the past trading day is −0.44%. Price change over the past year runs from +13.8% to +414.4% across the middle 80 percent of the group, with a median of +49.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $112.52B | Large cap | +40.77% | Nov 2, 2026 |
| 0HNC.L | BioMarin Pharmaceutical Inc. | $9.93B | Mid cap | +15.03% | Oct 26, 2026 |
| 0KBU.L | Omeros Corporation | $575.28M | Small cap | +332.86% | Nov 12, 2026 |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% | Sep 29, 2026 |
| 0A8E.L | Xeris Biopharma Holdings, Inc. | — | — | +10.86% | Nov 5, 2026 |
| 0ABW.L | Egetis Therapeutics AB (publ) | — | — | +58.43% | Nov 6, 2026 |
| 0K1R.L | Viridian Therapeutics, Inc. | — | — | +30.27% | Nov 5, 2026 |
| 0L49.L | SCYNEXIS, Inc. | — | — | +604.63% | Nov 4, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.